The Fortis Healthcare stock spurted nearly 12 per cent on reports that the company was in talks for an investment in its diagnostics subsidiary SRL. While Fortis clarified that it is talking to investors to facilitate the exit of existing private equity investors in SRL, there are other triggers as well.
Fortis Healthcare had increased its stake in SRL by 3.1 per cent to 57 per cent in September 2015 for Rs 105 crore. The transaction valued SRL at Rs 3,394 crore, much lower than what the Street was estimating.
Fortis Healthcare had increased its stake in SRL by 3.1 per cent to 57 per cent in September 2015 for Rs 105 crore. The transaction valued SRL at Rs 3,394 crore, much lower than what the Street was estimating.
